Insider Transactions in Q1 2023 at Standard Biotools Inc. (LAB)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Fenel M Eloi |
BUY
Grant, award, or other acquisition
|
Direct |
72,087
+50.0%
|
-
|
|
Feb 21
2023
|
Jeremy Steven Davis SVP Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,176
-29.65%
|
$12,352
$2.03 P/Share
|
|
Feb 21
2023
|
Jeremy Steven Davis SVP Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,833
+50.0%
|
-
|
|
Feb 21
2023
|
Vikram Jog Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,707
-11.65%
|
$57,414
$2.03 P/Share
|
|
Feb 21
2023
|
Vikram Jog Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,425
+5.61%
|
-
|
|
Feb 20
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
29,665
+28.03%
|
-
|